Literature DB >> 6889918

Etoposide and cis-platinum in non-small-cell bronchogenic carcinoma.

J Klastersky, E Longeval, C Nicaise, D Weerts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6889918     DOI： 10.1016/s0305-7372(82)80092-3

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  8 in total

Review 1.  Cytotoxic chemotherapy for common adult malignancies: "the emperor's new clothes" revisited?

Authors:  J H Kearsley
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-04

2.  Transient blindness and seizure associated with cisplatin therapy.

Authors:  M T Cattaneo; V Filipazzi; E Piazza; E Damiani; G Mancarella
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

Review 3.  Combination chemotherapy for advanced adenocarcinoma of the lung. A review.

Authors:  J B Sørensen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

4.  cis-platinum and etoposide combination chemotherapy of advanced non-oat cell bronchogenic carcinoma.

Authors:  A Veronesi; V Zagonel; M Santarossa; U Tirelli; E Galligioni; M G Trovo'; S Tumolo; E Grigoletto
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

5.  Ifosfamide, mitomycin and radiotherapy in non-small-cell lung cancer.

Authors:  S D Chetiyawardana; M H Cullen; R C Joshi; C M Woodroffe
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 6.  Cisplatin: a review of clinical applications and renal toxicity.

Authors:  D T Sleijfer; S Meijer; N H Mulder
Journal:  Pharm Weekbl Sci       Date:  1985-12-13

Review 7.  Current options in the treatment of non-small cell lung cancer.

Authors:  D Faulds
Journal:  Drugs       Date:  1992       Impact factor: 9.546

8.  Chemosensitivity testing of human lung cancer cell lines using the MTT assay.

Authors:  J Carmichael; J B Mitchell; W G DeGraff; J Gamson; A F Gazdar; B E Johnson; E Glatstein; J D Minna
Journal:  Br J Cancer       Date:  1988-06       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.